# FDA 483 - Marlinz Pharma, LLC - May 04, 2022

Source: https://www.keypedia.com/records/483/marlinz-pharma-llc/20798124-c205-4cf4-ab7d-976e5257db34

> FDA 483 for Marlinz Pharma, LLC on May 04, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Marlinz Pharma, LLC
- Inspection Date: 2022-05-04
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Marlinz Pharma, LLC, an own label distributor in Houston, revealed significant deficiencies in the firm's quality system regarding customer complaint handling. The company failed to adhere to its own standard operating procedures for documenting and processing complaints. This resulted in incomplete complaint records, specifically missing critical information such as initial contact details and the nature of the complaint.

## Related Officers

- [Investigator](https://www.keypedia.com/people/shatina-r-alridge/f4715fcf-fb27-4ef3-8289-adfff2db62bf)

Company: https://www.keypedia.com/companies/marlinz-pharma-llc/66897e87-8f53-4e28-86b4-e6db39fd3dce

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab